Fig. 6.
![Fig. 6. Whole blood coagulation and Integrilin. / Comparison of whole blood coagulation in the absence (▪) and presence (●) of 5 μM Integrilin. Coagulation was initiated in whole blood by 25 pM relipidated TF as described in “Materials and methods.” Panel A represents thrombin (TAT) generation, panel B fibrin (FPA) formation, and panel C platelet activation (osteonectin [ON] release). Arrow “a” indicates clotting times for the control experiment, arrow “b” for the Integrilin experiment.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/97/8/10.1182_blood.v97.8.2314/5/h80810935006.jpeg?Expires=1723709474&Signature=cJnyPWCbghJnwfZMs8e8topIYTR7jJJmV5qYLpjB61E2YaeBVtA5DPQhm8V6DtH5IS8einSSJZgartsAusoVJ6aN4suy5OM9Rn0rG7CaSMYeZJnvV5Muhzlv~pGExQSXWq-vkB9Tw8TU15tKbR6xOFmZZyKoQnzARhmhdAOl-q41rcpvR8viymWjJLZI7pOeWZcUtnp1K~C9uIjrQR9JM681VNJ02UmhAd2DxqFmDk97hayE4MORK9eyF8SL3SLeYx2h0xG5~hlg7HBFB874lLpo6fKbZWu--279iTkz7A5fODC5xJ1vDqKly7gCbdQx40tRlMzRnfYDHvlUgZva2g__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Whole blood coagulation and Integrilin.
Comparison of whole blood coagulation in the absence (▪) and presence (●) of 5 μM Integrilin. Coagulation was initiated in whole blood by 25 pM relipidated TF as described in “Materials and methods.” Panel A represents thrombin (TAT) generation, panel B fibrin (FPA) formation, and panel C platelet activation (osteonectin [ON] release). Arrow “a” indicates clotting times for the control experiment, arrow “b” for the Integrilin experiment.
